what happened to tirzepatide happens after stopping What happens when you stop weight-loss drugs like GLP-1 Tirzepatide for Weight Loss |

Figure 7 Vomiting According to the results, vomiting is more common in the treatment group (ROSE-010 at 100 g) than in the placebo group in all of the included investigations

Restore Your Metabolic Function If youve been struggling with weight loss resistance, blood sugar control, and/or other metabolic issues, there is likely an underlying reason

On 11 June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 medicine licensed in the UK for weight management

2 Gradual dose reduction not abrupt cessation Most trials (STEP-1 extension, SURMOUNT-4) stopped therapy abruptly at high dose

For mild local reactions limited to the injection site without systemic symptoms: Discontinue the injection if still in progress Apply a cold compress to reduce swelling and discomfort Avoid rubbing or massaging the affected area Monitor for progression over the next 2-4 hours Contact your healthcare provider if symptoms worsen or persist beyond 24 hours Document the reaction, including timing, appearance, and duration Mild local reactions may not require treatment discontinuation, but medical evaluation is necessary to determine whether subsequent doses are safe

STEP 1: In this pivotal trial, non-diabetic adults with a BMI of 30 or higher received a weekly 2.4mg dose of semaglutide (Wegovy) or a placebo